Skip to main content
Erschienen in: World Journal of Surgery 10/2020

05.06.2020 | Original Scientific Report with Video

Levels of Extracellular Vesicles in Pulmonary and Peripheral Blood Correlate with Stages of Lung Cancer Patients

verfasst von: Byeong Hyeon Choi, Yu Hua Quan, Jiyun Rho, Sunghoi Hong, Yong Park, Yeonho Choi, Ji -Ho Park, Hwan Seok Yong, Kook Nam Han, Young Ho Choi, Hyun Koo Kim

Erschienen in: World Journal of Surgery | Ausgabe 10/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

The extracellular vesicle (EV) concentration is known to be higher in cancer patients than in healthy individuals. Herein, we report that EV levels differ in the tumor-draining pulmonary vein blood and the peripheral blood of animal models and human subjects at different pathological stages of lung cancer.

Methods

Ten rabbits and 40 humans formed the study cohorts. Blood was collected from the peripheral vein of members of all groups. Pulmonary blood was collected intraoperatively from all groups except for the healthy human controls. Quantitative analysis of EV levels was performed using a nanoparticle tracking assay, a CD63 enzyme-linked immunosorbent assay, and western blotting.

Results

The EV levels in the peripheral blood of animals and patients with lung cancer were higher than those in the peripheral blood of healthy controls (p < 0.01 and p < 0.001, respectively). Moreover, for both animals and patients with lung cancer, the EV levels in the pulmonary blood were significantly higher than those in the preoperative peripheral blood (p < 0.01 and p < 0.0001, respectively). In patients, the pathological stages of lung cancer showed a higher correlation with the pulmonary EV levels than the peripheral EV levels.

Conclusions

EV levels increased with increasing lung cancer grade, and this trend was more prominent in the pulmonary blood than in the peripheral blood.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Blandin Knight S, Crosbie PA, Balata H et al (2017) Progress and prospects of early detection in lung cancer. Open Biol 7:170070CrossRef Blandin Knight S, Crosbie PA, Balata H et al (2017) Progress and prospects of early detection in lung cancer. Open Biol 7:170070CrossRef
2.
Zurück zum Zitat Reif MS, Socinski MA, Rivera MP (2000) Evidence-based medicine in the treatment of non-small-cell lung cancer. Clin Chest Med 21:107–120CrossRef Reif MS, Socinski MA, Rivera MP (2000) Evidence-based medicine in the treatment of non-small-cell lung cancer. Clin Chest Med 21:107–120CrossRef
3.
Zurück zum Zitat Bardelli A, Pantel K (2017) Liquid biopsies, what we do not know (yet). Cancer Cell 31:172–179CrossRef Bardelli A, Pantel K (2017) Liquid biopsies, what we do not know (yet). Cancer Cell 31:172–179CrossRef
4.
Zurück zum Zitat Crowley E, Di Nicolantonio F, Loupakis F et al (2013) Liquid biopsy: monitoring cancer-genetics in the blood. Nat Rev Clin Oncol 10:472CrossRef Crowley E, Di Nicolantonio F, Loupakis F et al (2013) Liquid biopsy: monitoring cancer-genetics in the blood. Nat Rev Clin Oncol 10:472CrossRef
5.
Zurück zum Zitat Martin OA, Anderson RL, Narayan K et al (2017) Does the mobilization of circulating tumour cells during cancer therapy cause metastasis? Nat Rev Clin Oncol 14:32CrossRef Martin OA, Anderson RL, Narayan K et al (2017) Does the mobilization of circulating tumour cells during cancer therapy cause metastasis? Nat Rev Clin Oncol 14:32CrossRef
6.
Zurück zum Zitat Nelson NJ (2010) Circulating tumor cells: will they be clinically useful? J Natl Cancer Inst 102:146–148CrossRef Nelson NJ (2010) Circulating tumor cells: will they be clinically useful? J Natl Cancer Inst 102:146–148CrossRef
7.
Zurück zum Zitat Okumura Y, Tanaka F, Yoneda K et al (2009) Circulating tumor cells in pulmonary venous blood of primary lung cancer patients. Ann Thorac Surg 87:1669–1675CrossRef Okumura Y, Tanaka F, Yoneda K et al (2009) Circulating tumor cells in pulmonary venous blood of primary lung cancer patients. Ann Thorac Surg 87:1669–1675CrossRef
8.
Zurück zum Zitat Hashimoto M, Tanaka F, Yoneda K et al (2014) Significant increase in circulating tumour cells in pulmonary venous blood during surgical manipulation in patients with primary lung cancer. Interact Cardiovasc Thorac Surg 18:775–783CrossRef Hashimoto M, Tanaka F, Yoneda K et al (2014) Significant increase in circulating tumour cells in pulmonary venous blood during surgical manipulation in patients with primary lung cancer. Interact Cardiovasc Thorac Surg 18:775–783CrossRef
9.
Zurück zum Zitat Chen K, Zhao H, Yang F et al (2018) Dynamic changes of circulating tumour DNA in surgical lung cancer patients: protocol for a prospective observational study. BMJ Open 8:e019012CrossRef Chen K, Zhao H, Yang F et al (2018) Dynamic changes of circulating tumour DNA in surgical lung cancer patients: protocol for a prospective observational study. BMJ Open 8:e019012CrossRef
10.
Zurück zum Zitat Théry C, Zitvogel L, Amigorena S (2002) Exosomes: composition, biogenesis and function. Nat Rev Immunol 2:569CrossRef Théry C, Zitvogel L, Amigorena S (2002) Exosomes: composition, biogenesis and function. Nat Rev Immunol 2:569CrossRef
11.
Zurück zum Zitat Boriachek K, Islam MN, Möller A et al (2018) Biological functions and current advances in isolation and detection strategies for exosome nanovesicles. Small 14:1702153CrossRef Boriachek K, Islam MN, Möller A et al (2018) Biological functions and current advances in isolation and detection strategies for exosome nanovesicles. Small 14:1702153CrossRef
12.
Zurück zum Zitat Kanninen KM, Bister N, Koistinaho J et al (2016) Exosomes as new diagnostic tools in CNS diseases. Biochim Biophys Acta 1862:403–410CrossRef Kanninen KM, Bister N, Koistinaho J et al (2016) Exosomes as new diagnostic tools in CNS diseases. Biochim Biophys Acta 1862:403–410CrossRef
13.
Zurück zum Zitat Properzi F, Logozzi M, Fais S (2013) Exosomes: the future of biomarkers in medicine. Biomark Med 7:769–778CrossRef Properzi F, Logozzi M, Fais S (2013) Exosomes: the future of biomarkers in medicine. Biomark Med 7:769–778CrossRef
14.
Zurück zum Zitat Khushman M, Bhardwaj A, Patel GK et al (2017) Exosomal markers (CD63 and CD9) expression pattern using immunohistochemistry in resected malignant and nonmalignant pancreatic specimens. Pancreas 46:782–788CrossRef Khushman M, Bhardwaj A, Patel GK et al (2017) Exosomal markers (CD63 and CD9) expression pattern using immunohistochemistry in resected malignant and nonmalignant pancreatic specimens. Pancreas 46:782–788CrossRef
15.
Zurück zum Zitat Yamashita T, Kamada H, Kanasaki S et al (2013) Epidermal growth factor receptor localized to exosome membranes as a possible biomarker for lung cancer diagnosis. Pharmazie 68:969–973PubMed Yamashita T, Kamada H, Kanasaki S et al (2013) Epidermal growth factor receptor localized to exosome membranes as a possible biomarker for lung cancer diagnosis. Pharmazie 68:969–973PubMed
16.
Zurück zum Zitat Li Y, Zhang Y, Qiu F et al (2011) Proteomic identification of exosomal LRG1: a potential urinary biomarker for detecting NSCLC. Electrophoresis 32:1976–1983CrossRef Li Y, Zhang Y, Qiu F et al (2011) Proteomic identification of exosomal LRG1: a potential urinary biomarker for detecting NSCLC. Electrophoresis 32:1976–1983CrossRef
17.
Zurück zum Zitat Li W, Li C, Zhou T et al (2017) Role of exosomal proteins in cancer diagnosis. Mol Cancer 16:145CrossRef Li W, Li C, Zhou T et al (2017) Role of exosomal proteins in cancer diagnosis. Mol Cancer 16:145CrossRef
18.
Zurück zum Zitat Matsumoto Y, Kano M, Akutsu Y et al (2016) Quantification of plasma exosome is a potential prognostic marker for esophageal squamous cell carcinoma. Oncol Rep 36:2535–2543CrossRef Matsumoto Y, Kano M, Akutsu Y et al (2016) Quantification of plasma exosome is a potential prognostic marker for esophageal squamous cell carcinoma. Oncol Rep 36:2535–2543CrossRef
19.
Zurück zum Zitat Caivano A, Laurenzana I, De Luca L et al (2015) High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders. Tumour Biol 36:9739–9752CrossRef Caivano A, Laurenzana I, De Luca L et al (2015) High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders. Tumour Biol 36:9739–9752CrossRef
20.
Zurück zum Zitat Logozzi M, De Milito A, Lugini L et al (2009) High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS ONE 4:e5219CrossRef Logozzi M, De Milito A, Lugini L et al (2009) High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS ONE 4:e5219CrossRef
21.
Zurück zum Zitat Vlassov AV, Magdaleno S, Setterquist R et al (2012) Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta 1820:940–948CrossRef Vlassov AV, Magdaleno S, Setterquist R et al (2012) Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta 1820:940–948CrossRef
22.
Zurück zum Zitat Choi BH, Young HS, Quan YH et al (2017) Real-time computed tomography fluoroscopy-guided solitary lung tumor model in a rabbit. PLoS ONE 12:e0179220CrossRef Choi BH, Young HS, Quan YH et al (2017) Real-time computed tomography fluoroscopy-guided solitary lung tumor model in a rabbit. PLoS ONE 12:e0179220CrossRef
23.
Zurück zum Zitat Colombo M, Raposo G, Théry C (2014) Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol 30:255–289CrossRef Colombo M, Raposo G, Théry C (2014) Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol 30:255–289CrossRef
24.
Zurück zum Zitat Navarro A, Molins L, Marrades RM et al (2019) Exosome analysis in tumor-draining pulmonary vein identifies NSCLC patients with higher risk of relapse after curative surgery. Cancers 11:249CrossRef Navarro A, Molins L, Marrades RM et al (2019) Exosome analysis in tumor-draining pulmonary vein identifies NSCLC patients with higher risk of relapse after curative surgery. Cancers 11:249CrossRef
25.
Zurück zum Zitat Carlsson A, Nair VS, Luttgen MS et al (2014) Circulating tumor microemboli diagnostics for patients with non–small-cell lung cancer. J Thorac Oncol 9:1111–1119CrossRef Carlsson A, Nair VS, Luttgen MS et al (2014) Circulating tumor microemboli diagnostics for patients with non–small-cell lung cancer. J Thorac Oncol 9:1111–1119CrossRef
26.
Zurück zum Zitat Murlidhar V, Reddy RM, Fouladdel S et al (2017) Poor prognosis indicated by venous circulating tumor cell clusters in early-stage lung cancers. Cancer Res 77:5194–5206CrossRef Murlidhar V, Reddy RM, Fouladdel S et al (2017) Poor prognosis indicated by venous circulating tumor cell clusters in early-stage lung cancers. Cancer Res 77:5194–5206CrossRef
27.
Zurück zum Zitat Skotland T, Sandvig K, Llorente A (2017) Lipids in exosomes: current knowledge and the way forward. Prog Lipid Res 66:30–41CrossRef Skotland T, Sandvig K, Llorente A (2017) Lipids in exosomes: current knowledge and the way forward. Prog Lipid Res 66:30–41CrossRef
28.
Zurück zum Zitat Simonsen JB (2017) What are we looking at? Extracellular vesicles, lipoproteins, or both? Circ Res 121:920–922CrossRef Simonsen JB (2017) What are we looking at? Extracellular vesicles, lipoproteins, or both? Circ Res 121:920–922CrossRef
Metadaten
Titel
Levels of Extracellular Vesicles in Pulmonary and Peripheral Blood Correlate with Stages of Lung Cancer Patients
verfasst von
Byeong Hyeon Choi
Yu Hua Quan
Jiyun Rho
Sunghoi Hong
Yong Park
Yeonho Choi
Ji -Ho Park
Hwan Seok Yong
Kook Nam Han
Young Ho Choi
Hyun Koo Kim
Publikationsdatum
05.06.2020
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 10/2020
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-020-05630-y

Weitere Artikel der Ausgabe 10/2020

World Journal of Surgery 10/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.